The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Infusions, Intravenous

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Infusions, Intravenous


Psychiatry related information on Infusions, Intravenous


High impact information on Infusions, Intravenous


Chemical compound and disease context of Infusions, Intravenous


Biological context of Infusions, Intravenous


Anatomical context of Infusions, Intravenous


Associations of Infusions, Intravenous with chemical compounds


Gene context of Infusions, Intravenous

  • Intravenous infusion of the p75TNF produced none of the hemodynamic changes seen after the infusion of TNF [36].
  • Intravenous infusion of gamma-MSH (0.2 pmol/min) for 30 min to PC2(-/-) mice after 1 week of HSD lowered MAP from hypertensive levels to normal; infusion of alpha-MSH at the same rate had no effect [37].
  • Concurrent with the injections, nine volunteers received a 3-hour continuous intravenous infusion of IL-1Ra [38].
  • After intravenous infusion, there was a tendency for the cells to engraft into the hippocampal region that was previously designated a "vascular niche." Migration assays suggested that preferential engraftment of RS-MSCs was in part explained by their expression of CXCR4 and CX3R1, the receptors for SDF-1 and fractalkine [39].
  • Because of this, the effects of single injections of GLP-1 are short-lasting, and for full demonstration of its antidiabetogenic effects, continuous intravenous infusion is required [40].

Analytical, diagnostic and therapeutic context of Infusions, Intravenous


  1. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger, S., Present, D.H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., Hanauer, S. N. Engl. J. Med. (1994) [Pubmed]
  2. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. Pizzo, P.A., Eddy, J., Falloon, J., Balis, F.M., Murphy, R.F., Moss, H., Wolters, P., Brouwers, P., Jarosinski, P., Rubin, M. N. Engl. J. Med. (1988) [Pubmed]
  3. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Swedberg, K., Held, P., Kjekshus, J., Rasmussen, K., Rydén, L., Wedel, H. N. Engl. J. Med. (1992) [Pubmed]
  4. Aspirin, heparin, or both to treat acute unstable angina. Théroux, P., Ouimet, H., McCans, J., Latour, J.G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P. N. Engl. J. Med. (1988) [Pubmed]
  5. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. Kreitman, R.J., Wilson, W.H., Bergeron, K., Raggio, M., Stetler-Stevenson, M., FitzGerald, D.J., Pastan, I. N. Engl. J. Med. (2001) [Pubmed]
  6. Physostigmine in mania. Davis, K.L., Berger, P.A., Hollister, L.E., Defraites, E. Arch. Gen. Psychiatry (1978) [Pubmed]
  7. Acute Wernicke's encephalopathy after intravenous infusion of high-dose nitroglycerin. Shorey, J., Bhardwaj, N., Loscalzo, J. Ann. Intern. Med. (1984) [Pubmed]
  8. Noradrenergic and serotonergic function in posttraumatic stress disorder. Southwick, S.M., Krystal, J.H., Bremner, J.D., Morgan, C.A., Nicolaou, A.L., Nagy, L.M., Johnson, D.R., Heninger, G.R., Charney, D.S. Arch. Gen. Psychiatry (1997) [Pubmed]
  9. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Abelson, J.L., Glitz, D., Cameron, O.G., Lee, M.A., Bronzo, M., Curtis, G.C. Arch. Gen. Psychiatry (1991) [Pubmed]
  10. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Dager, S.R., Marro, K.I., Richards, T.L., Metzger, G.D. The American journal of psychiatry. (1994) [Pubmed]
  11. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. Hoeper, M.M., Schwarze, M., Ehlerding, S., Adler-Schuermeyer, A., Spiekerkoetter, E., Niedermeyer, J., Hamm, M., Fabel, H. N. Engl. J. Med. (2000) [Pubmed]
  12. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. Negrier, S., Escudier, B., Lasset, C., Douillard, J.Y., Savary, J., Chevreau, C., Ravaud, A., Mercatello, A., Peny, J., Mousseau, M., Philip, T., Tursz, T. N. Engl. J. Med. (1998) [Pubmed]
  13. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. Barst, R.J., Rubin, L.J., Long, W.A., McGoon, M.D., Rich, S., Badesch, D.B., Groves, B.M., Tapson, V.F., Bourge, R.C., Brundage, B.H. N. Engl. J. Med. (1996) [Pubmed]
  14. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. Berenson, J.R., Lichtenstein, A., Porter, L., Dimopoulos, M.A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M.J., Blacklock, H.A., Bell, R., Simeone, J., Reitsma, D.J., Heffernan, M., Seaman, J., Knight, R.D. N. Engl. J. Med. (1996) [Pubmed]
  15. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome. Lacroix, A., Bolté, E., Tremblay, J., Dupré, J., Poitras, P., Fournier, H., Garon, J., Garrel, D., Bayard, F., Taillefer, R. N. Engl. J. Med. (1992) [Pubmed]
  16. Contaminated aqueous benzalkonium chloride. An unnecessary hospital infection hazard. Frank, M.J., Schaffner, W. JAMA (1976) [Pubmed]
  17. Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults. Blume, K.G., Beutler, E., Chillar, R.K., Fahey, J.L., Sharkoff, D., Zia, P.K. JAMA (1978) [Pubmed]
  18. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer. Hansen, R.M., Ryan, L., Anderson, T., Krzywda, B., Quebbeman, E., Benson, A., Haller, D.G., Tormey, D.C. J. Natl. Cancer Inst. (1996) [Pubmed]
  19. Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion. Mayer, G.P., Habener, J.F., Potts, J.T. J. Clin. Invest. (1976) [Pubmed]
  20. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusion due to phlebitis and extravasation. Wright, A., Hecker, J.F., Lewis, G.B. Lancet (1985) [Pubmed]
  21. Management of heparin therapy: Controlled prospective trial. Salzman, E.W., Deykin, D., Shapiro, R.M., Rosenberg, R. N. Engl. J. Med. (1975) [Pubmed]
  22. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Williams, D.A., Rios, M., Stephens, C., Patel, V.P. Nature (1991) [Pubmed]
  23. Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. Wong, J., Chou, L., Reid, I.A. J. Clin. Invest. (1993) [Pubmed]
  24. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. Conrad, K.P., Colpoys, M.C. J. Clin. Invest. (1986) [Pubmed]
  25. Bronchodilator action of inhaled nitric oxide in guinea pigs. Dupuy, P.M., Shore, S.A., Drazen, J.M., Frostell, C., Hill, W.A., Zapol, W.M. J. Clin. Invest. (1992) [Pubmed]
  26. Bronchodilatation: noncholinergic, nonadrenergic mediation demonstrated in vivo in the cat. Irvin, C.G., Boileau, R., Tremblay, J., Martin, R.R., Macklem, P.T. Science (1980) [Pubmed]
  27. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. Berendt, M.J., North, R.J. J. Exp. Med. (1980) [Pubmed]
  28. Comparison of acid secretory responsiveness to gastrin heptadecapeptide and of gastrin heptadecapeptide pharmacokinetics in duodenal ulcer patients and normal subjects. Blair, A.J., Richardson, C.T., Vasko, M., Walsh, J.H., Feldman, M. J. Clin. Invest. (1986) [Pubmed]
  29. Effects of a 3-day fast and of ethanol on splanchnic metabolism of FFA, amino acids, and carbohydrates in healthy young men. Wolfe, B.M., Havel, J.R., Marliss, E.B., Kane, J.P., Seymour, J., Ahuja, S.P. J. Clin. Invest. (1976) [Pubmed]
  30. Regulation of canine gallbladder motility by brain peptides. Lenz, H.J., Zimmerman, F.G., Messmer, B. Gastroenterology (1993) [Pubmed]
  31. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. May, D.C., Popma, J.J., Black, W.H., Schaefer, S., Lee, H.R., Levine, B.D., Hillis, L.D. N. Engl. J. Med. (1987) [Pubmed]
  32. Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. Hilsted, J., Richter, E., Madsbad, S., Tronier, B., Christensen, N.J., Hildebrandt, P., Damkjaer, M., Galbo, H. N. Engl. J. Med. (1987) [Pubmed]
  33. Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids. Batshaw, M., Brusilow, S., Walser, M. N. Engl. J. Med. (1975) [Pubmed]
  34. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. Speiser, P.W., Agdere, L., Ueshiba, H., White, P.C., New, M.I. N. Engl. J. Med. (1991) [Pubmed]
  35. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. McCune, W.J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., Fox, D.A. N. Engl. J. Med. (1988) [Pubmed]
  36. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. Welborn, M.B., Van Zee, K., Edwards, P.D., Pruitt, J.H., Kaibara, A., Vauthey, J.N., Rogy, M., Castleman, W.L., Lowry, S.F., Kenney, J.S., Stüber, D., Ettlin, U., Wipf, B., Loetscher, H., Copeland, E.M., Lesslauer, W., Moldawer, L.L. J. Exp. Med. (1996) [Pubmed]
  37. Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. Ni, X.P., Pearce, D., Butler, A.A., Cone, R.D., Humphreys, M.H. J. Clin. Invest. (2003) [Pubmed]
  38. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Granowitz, E.V., Porat, R., Mier, J.W., Orencole, S.F., Callahan, M.V., Cannon, J.G., Lynch, E.A., Ye, K., Poutsiaka, D.D., Vannier, E. Blood (1993) [Pubmed]
  39. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Lee, R.H., Hsu, S.C., Munoz, J., Jung, J.S., Lee, N.R., Pochampally, R., Prockop, D.J. Blood (2006) [Pubmed]
  40. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Holst, J.J., Deacon, C.F. Diabetes (1998) [Pubmed]
  41. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. England, M.R., Gordon, G., Salem, M., Chernow, B. JAMA (1992) [Pubmed]
  42. Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. Veldhuis, J.D., Dufau, M.L. J. Clin. Invest. (1987) [Pubmed]
  43. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. Liddle, R.A., Gertz, B.J., Kanayama, S., Beccaria, L., Coker, L.D., Turnbull, T.A., Morita, E.T. J. Clin. Invest. (1989) [Pubmed]
  44. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. Nienhuis, A.W., Donahue, R.E., Karlsson, S., Clark, S.C., Agricola, B., Antinoff, N., Pierce, J.E., Turner, P., Anderson, W.F., Nathan, D.G. J. Clin. Invest. (1987) [Pubmed]
  45. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. Polonsky, K.S., Licinio-Paixao, J., Given, B.D., Pugh, W., Rue, P., Galloway, J., Karrison, T., Frank, B. J. Clin. Invest. (1986) [Pubmed]
WikiGenes - Universities